The JAK/STAT signaling pathway: from bench to clinic
Xiaoying Hu, Jing Li, Maorong Fu, Xia Zhao, Wei Wang
2021.11.26Signal Transduction and Targeted Therapy
Paper details
- Journal
- Signal Transduction and Targeted Therapy
- Published
- 2021.11.26
- Citations
- 2,152
- References
- 568
- Access
- Open Access
- Fields
- Medicine
tlooto Summary
In this review, the current knowledge about the composition, activation, and regulation of the JAK/STAT pathway is discussed and the role of this signaling pathway and its inhibitors in various diseases is highlighted.
Abstract
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway was discovered more than a quarter-century ago. As a fulcrum of many vital cellular processes, the JAK/STAT pathway constitutes a rapid membrane-to-nucleus signaling module and induces the expression of various critical mediators of cancer and inflammation. Growing evidence suggests that dysregulation of the JAK/STAT pathway is associated with various cancers and autoimmune diseases. In this review, we discuss the current knowledge about the composition, activation, and regulation of the JAK/STAT pathway. Moreover, we highlight the role of the JAK/STAT pathway and its inhibitors in various diseases.
Citation format
HU, Xiaoying, et al. The JAK/STAT signaling pathway: From bench to clinic. Signal Transduction and Targeted Therapy, 2021, 6(1): 402.